image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

“…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …”

table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

“…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …”

image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

“…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …”

table5_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

“…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …”

table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

“…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …”

The statistical information of substrate-product pairs. by Xinfang Song (12400929)

Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File). by Farrokh Habibzadeh (12256529)

Effect of specimen processing and kill curves for the antibiotics in the PANTA supplement. by Shashikant Srivastava (4567591)

“…Both <b>(B)</b> Time-to-positive and <b>(C)</b> solid agar methods showed that the decontamination steps significantly decrease the recovery of the <i>M</i>. …”

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Variation in the energy fluxes per CS and the density of RCs of leaves of Baijinpao and Kangnaixin under Al stress. by Jing Zhang (23775)

Effect of collision material on COR. by Yifei Li (198040)

Data and statistical information for Figs 3–6. by Lindsay E. Martin (17377067)

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

S1 Dataset - by Hendricus Nijland (15198278)

“…</p><p>Results</p><p>MWA does not decrease mechanical strength in the diaphysis. In the metaphysis strength decreased up to 50% six weeks after ablation, which was not seen directly after ablation.…”

Potency and breadth of subject immune sera. by Chad D. Nix (8704143)

“…The plot for each serum shows the proportion of viruses neutralized by FRNT₅₀ at a given serum dilution. Each step in each plot represents an FRNT₅₀ value for one virus; as fold serum dilution increases for each serum, the proportion of viruses neutralized decreases by 1/11 (9.1%) as each FRNT₅₀ dilution for each virus is crossed. …”

Muscle fiber cross-section area and frequency distribution. by W. David Arnold (3373874)

Flowchart of patients. by Seydou Goro (17847203)

Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

Effects of HFD on mouse testicular morphology and BTB integrity. by Yong Fan (212624)